Vaccines
Protein Sciences' lead product candidates are vaccines to protect against seasonal and pandemic influenza. Influenza is a leading cause of illness and death around the world, resulting in an average of 220,000 hospitalizations and 36,000 deaths annually in the U.S. alone.
New strains of influenza with pandemic potential are continually emerging (i.e. H5N1) and are associated with high mortality rates (>70% mortality).
An independent market study (Datamonitor, 2007) has found that the world wide influenza vaccine market is growing fast and is predicted to more than double in size to over $7B by 2016.
Protein Sciences’ Product Pipeline
